SILK ROAD MEDICAL INC (SILK)
US82710M1009 - Common Stock
Taking everything into account, SILK scores 3 out of 10 in our fundamental rating. SILK was compared to 196 industry peers in the Health Care Equipment & Supplies industry. SILK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SILK is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SILK had negative earnings in the past year.
SILK had a negative operating cash flow in the past year.
SILK had negative earnings in each of the past 5 years.
SILK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -21.01%, SILK perfoms like the industry average, outperforming 53.57% of the companies in the same industry.
SILK has a Return On Equity (-36.88%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.01% | ||
| ROE | -36.88% | ||
| ROIC | N/A |
ROA(3y)-24.4%
ROA(5y)-27.56%
ROE(3y)-44.44%
ROE(5y)-50.06%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SILK has a better Gross Margin (71.75%) than 82.14% of its industry peers.
SILK's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for SILK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.75% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
SILK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SILK has more shares outstanding
Compared to 5 years ago, SILK has more shares outstanding
The debt/assets ratio for SILK is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.49 indicates that SILK is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.49, SILK is in the better half of the industry, outperforming 64.80% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that SILK is somewhat dependend on debt financing.
SILK has a Debt to Equity ratio of 0.50. This is in the lower half of the industry: SILK underperforms 64.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.49 |
ROIC/WACCN/A
WACC9.84%
2.3 Liquidity
A Current Ratio of 7.95 indicates that SILK has no problem at all paying its short term obligations.
SILK has a Current ratio of 7.95. This is amongst the best in the industry. SILK outperforms 86.22% of its industry peers.
A Quick Ratio of 6.97 indicates that SILK has no problem at all paying its short term obligations.
SILK's Quick ratio of 6.97 is amongst the best of the industry. SILK outperforms 84.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.95 | ||
| Quick Ratio | 6.97 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.49% over the past year.
SILK shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.78%.
The Revenue has been growing by 38.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)6.49%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q2.94%
Revenue 1Y (TTM)27.78%
Revenue growth 3Y33.05%
Revenue growth 5Y38.63%
Revenue growth Q2Q17.97%
3.2 Future
The Earnings Per Share is expected to grow by 3.87% on average over the next years.
The Revenue is expected to grow by 13.50% on average over the next years. This is quite good.
EPS Next Y1.33%
EPS Next 2Y3.92%
EPS Next 3Y3.94%
EPS Next 5Y3.87%
Revenue Next Year13.99%
Revenue Next 2Y12.57%
Revenue Next 3Y11.82%
Revenue Next 5Y13.5%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
SILK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SILK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.92%
EPS Next 3Y3.94%
5. Dividend
5.1 Amount
No dividends for SILK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SILK ROAD MEDICAL INC
NASDAQ:SILK (4/15/2024, 7:00:02 PM)
After market: 18.05 0 (0%)18.05
-0.15 (-0.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap707.02M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.01% | ||
| ROE | -36.88% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.75% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.95 | ||
| Quick Ratio | 6.97 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)6.49%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y1.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.78%
Revenue growth 3Y33.05%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y